153 related articles for article (PubMed ID: 17828494)
1. Expression of survivin and its splice variants in gastric cancer.
Cheng Z; Hu L; Fu W; Zhang Q; Liao X
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):393-8. PubMed ID: 17828494
[TBL] [Abstract][Full Text] [Related]
2. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.
Meng H; Lu CD; Sun YL; Dai DJ; Lee SW; Tanigawa N
World J Gastroenterol; 2004 Nov; 10(22):3245-50. PubMed ID: 15484293
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of survivin splicing variants in expression gastric cancer].
Meng H; Dai DJ; Lu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
7. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers.
Mishra R; Palve V; Kannan S; Pawar S; Teni T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):497-507. PubMed ID: 26346910
[TBL] [Abstract][Full Text] [Related]
8. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
De Maria S; Pannone G; Bufo P; Santoro A; Serpico R; Metafora S; Rubini C; Pasquali D; Papagerakis SM; Staibano S; De Rosa G; Farina E; Emanuelli M; Santarelli A; Mariggiò MA; Lo Russo L; Lo Muzio L
J Cancer Res Clin Oncol; 2009 Jan; 135(1):107-16. PubMed ID: 18642030
[TBL] [Abstract][Full Text] [Related]
9. [Expression of survivin and its splice variants in gastric cancer].
Cheng ZJ; Hu LH; Fu WR; Zhang Q
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):130-1. PubMed ID: 18681327
[No Abstract] [Full Text] [Related]
10. [Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance].
Meng H; Lu CD; Dai DJ; Sun YL; Tanigawa N
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2060-3. PubMed ID: 15730616
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
[TBL] [Abstract][Full Text] [Related]
13. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.
Ikeguchi M; Kaibara N
Int J Mol Med; 2001 Dec; 8(6):661-6. PubMed ID: 11712083
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
16. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
17. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
18. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
[TBL] [Abstract][Full Text] [Related]
19. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
[TBL] [Abstract][Full Text] [Related]
20. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
